POU5F1 and cancer: The results showed that the OCT4-positive rate was significantly higher in ECC patients with poorly differentiated cancer cells, lymph node metastasis, or late clinical stage; the VEGF-C positive rate was significantly higher in cancer tissues with lymph node metastasis than that without lymph node metastasis.